Efficacy of galcanezumab in patients with episodic migraine and a history of preventive treatment failure: results from two global randomized clinical trials

Author(s):
Ruff, D.D.; Ford, J.H.; Tockhorn-Heidenreich, A.; Stauffer, V.L.; Govindan, S.; Aurora, S.K.; Terwindt, G.M.; Goadsby, P.J.
Published
2019
Publication type
Article / Letter to editor
episodic migrainegalcanezumabLY2951742phase 3preventive failure
Date issued
2019-12-02
Language
English
Is part of
European Journal of Neurology
hdl
1887/120754
doi
10.1111/ene.14114